The economic cost of cancer in adolescents and young adults | Deloitte Australia | Deloitte Access Economics, Health care has been added to your bookmarks.
The economic cost of cancer in adolescents and young adults
Assessing the impact
Deloitte Access Economics has undertaken an analysis of the economic cost of cancer in adolescents and young adults for CanTeen.
Deloitte Access Economics was commissioned by CanTeen to undertake an analysis of the economic cost of cancer in adolescents and young adults (AYAs) in 2016. For the purpose of this report, AYAs are defined as those people who are aged 15-25 years old in 2016.
The economic costs of cancer are many and varied. The scope of costs for this report has been limited to: health system costs, productivity costs (absenteeism, workforce participation, premature mortality, productivity-related administrative costs, and informal carer costs), deadweight losses (DWLs) and the burden of disease.
- There were estimated to be almost 1,100 AYAs diagnosed with cancer in 2016.
- There were estimated to be 112 AYAs who would die from cancer in 2016.
- The lifetime cost of healthcare for AYAs diagnosed with cancer in 2016 was estimated to be $146.5 million.
- The total lifetime productivity costs were estimated at $508.4 million.
- The associated deadweight loss (DWL) was estimated to be $87.0 million.
- The value of the burden of disease from all cancers in AYAs diagnosed in 2016 was estimated to be $701.4 million.
Published: January 2018